InsideTrading SEC Form 4 insider trades
← All clusters
ELVN

Enliven Therapeutics, Inc.

Healthcare Pharmaceutical Preparations Market cap: $3.6B Ticker page → Watch ELVN (just your e-mail) Price alert (just your e-mail)

Limited buying: $73.6M bought (counted up to $5.0M); 11 distinct insiders. Holding it back: largest buyer: Bonita David P (Director), 20% of the dollars.

55
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. <60 · limited buying
-250.0%
Since the cluster formed, vs benchmark (-21.8% raw)

Score, not a recommendation.

Total bought$73.6M11 Form 4 purchases
Distinct insiders11open-market buyers
Insiders' average price$16.00no price on the purchase days
Cluster window2020-03-12 → 2020-03-16closed

partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Price history is incomplete; missing inputs count as neutral in the score.

Price and insider purchases

Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.

Loading price history…

How the score adds up

How each input is counted →
Points each input adds to the score, and how much of the points it could give it has
Input Strength Points
$73.6M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. 100% +57
11 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. 100% +15
No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. 0% +0
Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. 0% +0
4 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. 93% +0
Routine or plan purchases: 0% of the dollarsThe share of the dollars in routine or plan purchases (a Rule 10b5-1 plan, dividend reinvestment, a regular cadence). All of it routine would take off 5.6 points. 100% +0
Largest buyer: Bonita David P (Director), 20% of the dollarsThe share of the dollars bought by the largest buyer. Buying spread evenly keeps the points; one buyer paying for everything takes off 12.7. 88% -3
Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast.69
Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering)-14
Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation.55

Why are they buying?

No explanation has been generated for this cluster. The filings in the table below are the primary evidence.

Transactions

11 Form 4 trades · 11 insiders Download CSV Up to 5,000 rows
Purchases in this cluster, grouped by insider, largest first
Date InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. Role Shares Price Value Flags Filing
2020-03-12 ORBIMED ADVISORS LLC history of ORBIMED ADVISORS LLC's purchases Director 937,500 $16.00 $15.0M
offering
SEC filing for ORBIMED ADVISORS LLC (opens in a new tab)
2020-03-12 Bonita David P history of Bonita David P's purchases Director 937,500 $16.00 $15.0M
offering
SEC filing for Bonita David P (opens in a new tab)
2020-03-16 RA Capital Healthcare Fund LP 3 purchases with a 63-day result · median -5.9% 10% owner 625,000 $16.00 $10.0M
offering
SEC filing for RA Capital Healthcare Fund LP (opens in a new tab)
2020-03-16 KERINS PATRICK J history of KERINS PATRICK J's purchases 10% owner 475,000 $16.00 $7.6M
offering
SEC filing for KERINS PATRICK J (opens in a new tab)
2020-03-16 Dalton Barbara history of Dalton Barbara's purchases Director 312,500 $16.00 $5.0M
offering
SEC filing for Dalton Barbara (opens in a new tab)
2020-03-16 PFIZER INC history of PFIZER INC's purchases 10% owner 312,500 $16.00 $5.0M
offering
SEC filing for PFIZER INC (opens in a new tab)
2020-03-16 Rock Springs Capital Management LP history of Rock Springs Capital Management LP's purchases 10% owner 250,000 $16.00 $4.0M
offering
SEC filing for Rock Springs Capital Management LP (opens in a new tab)
2020-03-16 Arix Bioscience plc history of Arix Bioscience plc's purchases 10% owner 187,500 $16.00 $3.0M
offering
SEC filing for Arix Bioscience plc (opens in a new tab)
2020-03-16 Lundbeckfond Invest A/S history of Lundbeckfond Invest A/S's purchases 10% owner 187,500 $16.00 $3.0M
offering
SEC filing for Lundbeckfond Invest A/S (opens in a new tab)
2020-03-16 Chin Mark history of Chin Mark's purchases Director 187,500 $16.00 $3.0M
offering
SEC filing for Chin Mark (opens in a new tab)
2020-03-16 Agger Mette Kirstine history of Agger Mette Kirstine's purchases Director 187,500 $16.00 $3.0M
offering
SEC filing for Agger Mette Kirstine (opens in a new tab)
Total $73.6M

Other buying runs at ELVN

A buying runPurchases at one company with no pause longer than the cluster rule allows. A long pause ends the run, so one company can have several. ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmarkThe index a stock's return is compared with: a small-cap index for small companies, a large-cap index otherwise. (IWM for small companies, SPY otherwise), from the first open after the buying run became a cluster. Past results, not a forecast.

After this buying run became a cluster, vs benchmark: 21 days -11.6% (+3.0% raw)63 days +116.1% (+144.5% raw)126 days +5.6% (+45.8% raw)

Other insider buying runs at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2021-07-16 3 $28.0M 51 -17.3% (-16.7% raw)-40.6% (-36.3% raw)-65.7% (-75.7% raw) closed